Kristy Gottfried1, Robbie Quinn, Tim Jones. 1. Tennessee Department of Health, Communicable and Environmental Disease Service, Nashville, TN 37247-3901, USA.
Abstract
OBJECTIVES: The objective of this study was to investigate long-term outcomes after West Nile virus infection. METHODS: We reviewed the medical records of persons reported with West Nile virus in Tennessee in 2002 and interviewed cases 1 year after acute illness. RESULTS: In 2002, 56 cases of West Nile virus were reported in Tennessee; 48 (84%) had meningitis or encephalitis. Of those, 9 (19%) died during acute infection and 12 (25%) died within 6 months of illness onset. Patients with West Nile virus neurologic illness spent a median of 10 days in the hospital and were unable to resume normal activities for a median of 25 days. One year later, 12 of 22 (55%) persons reported that they were not fully recovered, with symptoms including fatigue, weakness, difficulty ambulating, and memory problems. CONCLUSIONS: West Nile virus infection leads to high rates of mortality and substantial persistent morbidity. Prevention efforts should be targeted to populations at highest risk of severe sequelae.
OBJECTIVES: The objective of this study was to investigate long-term outcomes after West Nile virus infection. METHODS: We reviewed the medical records of persons reported with West Nile virus in Tennessee in 2002 and interviewed cases 1 year after acute illness. RESULTS: In 2002, 56 cases of West Nile virus were reported in Tennessee; 48 (84%) had meningitis or encephalitis. Of those, 9 (19%) died during acute infection and 12 (25%) died within 6 months of illness onset. Patients with West Nile virus neurologic illness spent a median of 10 days in the hospital and were unable to resume normal activities for a median of 25 days. One year later, 12 of 22 (55%) persons reported that they were not fully recovered, with symptoms including fatigue, weakness, difficulty ambulating, and memory problems. CONCLUSIONS: West Nile virus infection leads to high rates of mortality and substantial persistent morbidity. Prevention efforts should be targeted to populations at highest risk of severe sequelae.
Authors: Robert L Cook; Xiaohui Xu; Eric J Yablonsky; Nikole Sakata; Jennifer H Tripp; Rachel Hess; Paolo Piazza; Charles R Rinaldo Journal: Am J Trop Med Hyg Date: 2010-11 Impact factor: 2.345
Authors: Kim K Appler; Ashley N Brown; Barbara S Stewart; Melissa J Behr; Valerie L Demarest; Susan J Wong; Kristen A Bernard Journal: PLoS One Date: 2010-05-14 Impact factor: 3.240
Authors: Jessica B Graham; Sunil Thomas; Jessica Swarts; Aimee A McMillan; Martin T Ferris; Mehul S Suthar; Piper M Treuting; Renee Ireton; Michael Gale; Jennifer M Lund Journal: MBio Date: 2015-05-05 Impact factor: 7.867
Authors: N Ouhoumanne; A-M Lowe; A Fortin; D Kairy; A Vibien; J K-Lensch; T-N Tannenbaum; F Milord Journal: Epidemiol Infect Date: 2018-03-28 Impact factor: 4.434
Authors: Kristy O Murray; Melissa N Garcia; Mohammad H Rahbar; Diana Martinez; Salma A Khuwaja; Raouf R Arafat; Susan Rossmann Journal: PLoS One Date: 2014-07-23 Impact factor: 3.240